Cargando…
Science review: The use of proton pump inhibitors for gastric acid suppression in critical illness
Prophylaxis is routinely provided for critically ill patients admitted to intensive care units (ICUs) who are at high risk for stress-related mucosal damage (SRMD), an erosive process of the gastroduodenum associated with abnormally high physiological demands. Traditionally, treatment options have i...
Autor principal: | Brett, Stephen |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1065099/ https://www.ncbi.nlm.nih.gov/pubmed/15693983 http://dx.doi.org/10.1186/cc2980 |
Ejemplares similares
-
Effect of proton pump inhibitors on gastric volume, gastric pH and gastric intramucosal pH in critically ill patients in the ICU
por: Gursoy, O, et al.
Publicado: (2006) -
Use of proton pump inhibitors for the risk of gastric cancer
por: Gao, Huiqin, et al.
Publicado: (2022) -
The risks of long-term use of proton pump inhibitors: a critical
review
por: Jaynes, Megan, et al.
Publicado: (2018) -
Proton Pump Inhibitors Should be Used with Caution in Critically Ill Patients to Prevent the Risk of Clostridium difficile Infection
por: Min, Jung Hwa, et al.
Publicado: (2016) -
Gastric Epithelial Cell Modality and Proton Pump Inhibitor
por: Masaoka, Tatsuhiro, et al.
Publicado: (2008)